(Press-News.org) Tampa, Fla. (July 11, 2011) – Two papers published in the current issue of Cell Transplantation (20:5), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, highlight the therapeutic potential of human Sertoli cells that are present in the testes and are also called "nurse" or "mother" cells because they nurture the developing sperm cells. Sertoli cells form the blood-testes barrier that separates the blood compartment of the testes from the compartment of the seminiferous tubules. Once differentiated to form the blood-testes barrier, Sertoli cells do not proliferate, although recent research has been aimed at growing Sertoli cells outside of the body.
Determining Sertoli cell functionality in vitro
A team of U.S. and Argentina-based researchers reporting on isolating and characterizing Sertoli cells from deceased human organ/tissue donors report on techniques by which Sertoli cells "proliferated readily" in vitro under "optimized conditions" with a four day "doubling time."
"Since there is interest in using Sertoli cells to minimize transplant rejection due to their immunological suppressive properties, establishing conditions to produce proliferative human Sertoli cells in vitro could facilitate research on their use for therapeutic applications in cell or organ transplantation," said study corresponding author Dr. Constance M. John of San Francisco-based MandalMed, Inc. "In this study we aimed to isolate and expand primary adult human Sertoli cells from cadaveric testes and characterize them to determine their functionality in vitro."
The researchers found that expanded, cryopreserved Sertoli cells could retain their characteristic markers and exhibited prototype functionality to establish a tight junction barrier.
"The cells provided evidence of potential utility in spermatogenesis and infertility research and reproductive toxicology," concluded the researchers. "Because of their robust proliferative activity and unique biological role, the primary Sertoli cells could have cell therapy applications."
Contact: Dr. Constance M. John, MandalMed, Inc. 665 3rd St. Suite 250,
San Francisco, CA 94107
Tel. (415) 495-5570
Fax. (415) 495- 5575
Email: constancejohn@mandalmed.com
Citation: Chui, K. ; Trivedi, A. ; Cheng, C. Y.; Cherbavaz, D. B.; Dazin, P. F. ; Huynh, A. L. T.; Mitchell, J. B.; Rabinovich, G. A.; Noble-Haeusslein, L. J.; John, C. M. Characterization and Functionality of Proliferative Human Sertoli Cells. Cell Transplant. 20(5):619-635;_2011.
Sertoli cells successfully deliver therapeutics deep into the lung
In a study seeking a better way to get medication to lower lung areas, such as to the alveoli and other areas difficult to reach and in which to retain therapeutics, University of South Florida (USF) researchers report that rat Sertoli cells loaded with chitosan nanoparticles and coupled with an anti-inflammatory compound, injected into the tails of mice with deep inflammation, reached the deep areas of the lung quickly and stayed active.
Current lung therapy techniques, such as aerosols, nebulizer mists, Metered Dose Inhalers and other means have proven largely ineffective because of airway obstructions, mucus, and airway edema that often prevent inhaled delivery. Even when these therapeutics are delivered effectively, they are often quickly expelled during exhalation and the drug is not in the lung long enough for sustained release.
"A novel way to deliver nanoparticles coupled with drugs to the deep lung is to utilize a bio-compatible cell-based system and deliver therapy through the peripheral vasculature instead of a pulmonary route," said corresponding author Dr. Donald F. Cameron of the University of South Florida (USF) Department of Pathology and Cell Biology.
The USF study tested the delivery of an anti-inflammatory compound to the deep lungs of animals modeled with pulmonary inflammation and found a "high therapeutic effect" 24 hours after drug delivery.
"The drug-loaded Sertoli cells became entrapped in the host animal's deep lung and was distributed around the alveoli while intact Sertoli cells were not detected in other tissues or organs," said Dr. Cameron. "At 15 minutes post injection, 92 percent of the labeled nanoparticle load in the injected Sertoli cells were present in the lungs with a minimal amount detected in the liver and kidney."
The researchers concluded that the use of pre-loaded Sertoli cells to deliver therapeutic nanoparticles to the lungs through the peripheral vasculature and subsequently migrated to the pulmonary vasculature, potentially providing an effective therapeutic alternative to current methodologies that have been proven less effective.
"These two studies describe a set of conditions for expanding human sertoli cells in vitro from deceased organ/tissue donors and a potential use for the cells (this time taken from rats)" said Dr. Camillo Ricordi, coeditor-in-chief of Cell Transplantation and Director of the Cell Transplant Center and Diabetes Research Institute at the University of Miami. "While the second paper covers the potential use of sertoli cells as vectors for the delivery of specific factors to the deep areas of the lung, these cells may also be beneficial as delivery systems for other disorders. This will require further investigation."
Contact: Dr. D.F. Cameron, MDC 11, Department of Pathology & Cell Biology, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd. Tampa, FL 33612
Tel. (813) 974-9434
Fax. (813) 974-2058
Citation: Kumar, A.; Glam, M.; El-Badri, N.; Mohapatra, S.; Haller, E.; Park, S.; Patrick, L.; Nattkemper, L.; Vo, D.; Cameron, D. F. Initial Observations of Cell-Mediated Drug Delivery to the Deep Lung. Cell Transplant. 20(5):609-618; 2011.
###
The editorial offices for Cell Transplantation are at the Center of Excellence for Aging and Brain Repair, College of Medicine, the University of South Florida and the Diabetes Research Institute, University of Miami Miller School of Medicine. Contact, David Eve, PhD. at celltransplantation@gmail.com or Camillo Ricordi, MD at ricordi@miami.edu
News release by Randolph Fillmore, Florida Science Communications, www.sciencescribe.net
END
WASHINGTON – Pets can serve as important sources of social and emotional support for "everyday people," not just individuals facing significant health challenges, according to research published by the American Psychological Association.
And, the study found, pet owners were just as close to key people in their lives as to their animals, indicating no evidence that relationships with pets came at the expense of relationships with other people, or that people relied more on pets when their human social support was poorer.
Psychologists at Miami University and Saint ...
INDIANAPOLIS – Indiana University and Regenstrief Institute researchers report that it takes significantly longer for orders to forgo resuscitation in the event of cardiac arrest to be written for patients who had that decision made for them by a surrogate decision-maker compared to patients who made their own decisions, even though patients with a surrogate were sicker and the resuscitation issue might arise sooner. Among patients who died, patients with a surrogate had a shorter time frame between writing the DNR order and time of death compared to patients who made ...
Researchers in the US are testing biofilter systems as a viable alternative to releasing methane from passive landfill vents into the atmosphere. The technology could reduce the overall impact of old landfills on global warming. Details are reported in the current issue of the International Journal of Environmental Engineering.
Organic matter rotting in smaller, old landfill sites generates a slow trickle of the potent greenhouse gas, methane, into the atmosphere, amounting to just 2 or 3 kilograms per day per vent. In contrast to controlled methane generate for biofuel ...
Carlos Bello, executive director of the Mexican Federation of Aerospace Industries, recently sat down with The Offshore Group to discuss the current state of affairs in Mexico's rapidly developing aerospace sector.
During the session, Bello informed that Mexico is currently home to 232 aerospace and aerospace industry related companies that employ a combined 29,000 workers. According to Bello, "In recent years, aerospace manufacturing in Mexico has been "experiencing a growth rate of about 20% annually, with the exception of 2009, which was a difficult year ...
Alexandria, VA – China sent the high-tech industry and markets reeling last fall when it blocked exports of raw rare earth minerals to Japan, Europe and the U.S. The sudden severing of rare earths supply was a frightening prospect as the minerals are key ingredients in a broad range of high-tech products, from smartphones to wind turbines and hybrid cars. Although the bans have since been lifted, governments around the world saw the ban as a kind of wake-up call and started looking at ways to develop their own mineral resources — for rare earths as well as basic industry ...
Tel Aviv — Most marketing departments work hard to establish a flawless reputation for their product or service. But new research from Tel Aviv University is showing that perfection is not all it's cracked up to be.
Dr. Danit Ein-Gar of Tel Aviv University's Faculty of Management at the Leon Recanati Graduate School of Business Administration, working in collaboration with Baba Shiv and Zakary Tormala from Stanford University, has uncovered the "blemishing effect," a counterintuitive benefit of negative information. When utilized in the right way, she says, a small flaw ...
TORONTO, Ont., July 11, 2011—More patients are tested and treated for osteoporosis when fracture clinics have someone dedicated to screening for the bone disease, a new study has found.
Those patients also do better when the clinic actually provides bone mineral density (BMD) testing or prescription drug treatment as part of its program rather than just referring fracture patients elsewhere.
Researchers at St. Michael's Hospital led by Joanna Sale, a clinical epidemiologist, reviewed osteoporosis screening and management programs involving patients treated for fragility ...
Data Match Solutions today released DataMatch Tool 2.0, a very powerful software to match and merge databases. This software helps researchers, faculty and students to save valuable time and effort to collect and analyse data for their projects.
Academics can now take their research to a higher level
With DataMatch Tool 2.0 (DMT 2.0), researchers can link data from different sources easily and quickly and take their research to a higher level.
Based on their experience in academic research and their knowledge in data collection and analysis, researchers from Data ...
An extract of the poisonous shrub Jatropha curcas acts as a strong painkiller and may have a mode of action different from conventional analgesics, such as morphine and other pharmaceuticals. Details of tests are reported in the current issue of the International Journal of Biomedical Engineering and Technology.
Omeh Yusuf and Ezeja Maxwell of the Micheal Okpara University of Agriculture in Umudike, Nigeria, explain how J. curcas, also known as the "physic nut" is a perennial shrub that grows to 5 meters in height and belongs to the Euphobiaceace family. It is native ...
Online consumers thought to be motivated primarily by savings are, in fact, often willing to pay a premium for purchases from online vendors with clear, protective privacy policies, according to a new study in the current issue of a journal of the Institute for Operations Research and the Management Sciences (INFORMS®).
"The Effect of Online Privacy Information on Purchasing Behavior: An Experimental Study" is by Janice Y. Tsai, Serge Egelman, Lorrie Cranor, and Alessandro Acquisti of Carnegie Mellon University. The study appears in the current issue of the INFORMS journal ...
